Business
Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
ROCHESTER HILLS, Mich., December 10, 2025--Ambulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026
About this update from Infusystems Holdings, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1815,"height":573,"url":"https://media.zenfs.com/en/business-wire.com/4a13e8baf5e1e0c700593b548b0db469"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/d7jjz658E54tyIPrmWrcXw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwMztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/4a13e8baf5e1e0c700593b548b0db469","width":960,"height":303},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/h9z1vVFOlDlpB26963J9vA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/4a13e8baf5e1e0c700593b548b0db469","width":1200,"height":379}},"lazy":false},{"type":"text","content":"ROCHESTER HILLS, Mich., December 10, 2025--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Centers for Medicare and Medicaid Services ("CMS") has added two of the electronic infusion pumps currently utilized by the Company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation ("NOPAIN") Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027 when provided with a covered surgical procedure. This payment may now be available to InfuSystem’s current and potential Pain Management customers for certain patients. This initiative is part of a broader strategy by CMS to combat the opioid crisis by promoting safer pain management alternatives. The two pumps are the CADD-Solis™ manufactured by ICU Medical, Inc., and Eitan Medical’s Sapphire™ pump.","length":1195,"tagName":"p"},{"type":"text","content":"Carrie Lachance, InfuSystem CEO, commented on the decision, stating, "We are very glad to see that CMS has expanded upon its initial decision from last year and acknowledged that electronic infusion pumps such as the CADD-Solis™ and the Sapphire™ are effective non-opioid options for reducing opioid use after surgery. We will continue to work in partnership with healt...